Literature DB >> 21248718

Kidney preservation by bone marrow cell transplantation in hereditary nephropathy.

Brian A Yeagy1, Frank Harrison, Marie-Claire Gubler, James A Koziol, Daniel R Salomon, Stephanie Cherqui.   

Abstract

The prospect of cell-based therapy for kidney disease remains controversial despite its immense promise. We had previously shown that transplanting bone marrow and hematopoietic stem cells could generate renal cells and lead to the preservation of kidney function in a mouse model for cystinosis (Ctns(-/-)) that develops chronic kidney injury, 4 months post transplantation. Here, we determined the long-term effects of bone marrow stem cell transplantation on the kidney disease of Ctns(-/-) mice 7 to 15 months post transplantation. Transfer of bone marrow stem cells expressing a functional Ctns gene provided long-term protection to the kidney. Effective therapy, however, depended on achieving a relatively high level of donor-derived blood cell engraftment of Ctns-expressing cells, which was directly linked to the quantity of these cells within the kidney. In contrast, kidney preservation was dependent neither on renal cystine content nor on the age of the mice at the time of transplant. Most of the bone marrow-derived cells within the kidney were interstitial and not epithelial, suggesting that the mechanism involved an indirect protection of the tubules. Thus, our model may help in developing strategies to enhance the potential success of cell-based therapy for kidney injury and in understanding some of the discrepancies currently existing in the field.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21248718     DOI: 10.1038/ki.2010.537

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  29 in total

1.  Interaction between galectin-3 and cystinosin uncovers a pathogenic role of inflammation in kidney involvement of cystinosis.

Authors:  Tatiana Lobry; Roy Miller; Nathalie Nevo; Celine J Rocca; Jinzhong Zhang; Sergio D Catz; Fiona Moore; Lucie Thomas; Daniel Pouly; Anne Bailleux; Ida Chiara Guerrera; Marie-Claire Gubler; Wai W Cheung; Robert H Mak; Tristan Montier; Corinne Antignac; Stephanie Cherqui
Journal:  Kidney Int       Date:  2019-03-06       Impact factor: 10.612

2.  Brief reports: Lysosomal cross-correction by hematopoietic stem cell-derived macrophages via tunneling nanotubes.

Authors:  Swati Naphade; Jay Sharma; Héloïse P Gaide Chevronnay; Michael A Shook; Brian A Yeagy; Celine J Rocca; Sarah N Ur; Athena J Lau; Pierre J Courtoy; Stephanie Cherqui
Journal:  Stem Cells       Date:  2015-01       Impact factor: 6.277

3.  Cysteamine therapy: a treatment for cystinosis, not a cure.

Authors:  Stephanie Cherqui
Journal:  Kidney Int       Date:  2012-01       Impact factor: 10.612

4.  A mouse model suggests two mechanisms for thyroid alterations in infantile cystinosis: decreased thyroglobulin synthesis due to endoplasmic reticulum stress/unfolded protein response and impaired lysosomal processing.

Authors:  H P Gaide Chevronnay; V Janssens; P Van Der Smissen; X H Liao; Y Abid; N Nevo; C Antignac; S Refetoff; S Cherqui; C E Pierreux; P J Courtoy
Journal:  Endocrinology       Date:  2015-03-26       Impact factor: 4.736

Review 5.  Stem cells as a therapeutic approach to chronic kidney diseases.

Authors:  Sargis Sedrakyan; Susanne Angelow; Roger E De Filippo; Laura Perin
Journal:  Curr Urol Rep       Date:  2012-02       Impact factor: 3.092

Review 6.  Potential use of stem cells as a therapy for cystinosis.

Authors:  Celine J Rocca; Stephanie Cherqui
Journal:  Pediatr Nephrol       Date:  2018-05-22       Impact factor: 3.714

7.  N-acetyl-cysteine is associated to renal function improvement in patients with nephropathic cystinosis.

Authors:  Luciana Pache de Faria Guimaraes; Antonio Carlos Seguro; Maria Heloisa Mazzola Shimizu; Letícia Aparecida Lopes Neri; Nairo Massakasu Sumita; Ana Carolina de Bragança; Rildo Aparecido Volpini; Talita Rojas Cunha Sanches; Fernanda Andrade Macaferri da Fonseca; Carlos Alberto Moreira Filho; Maria Helena Vaisbich
Journal:  Pediatr Nephrol       Date:  2013-12-11       Impact factor: 3.714

Review 8.  Is genetic rescue of cystinosis an achievable treatment goal?

Authors:  Stephanie Cherqui
Journal:  Nephrol Dial Transplant       Date:  2013-07-16       Impact factor: 5.992

9.  Nephropathic cystinosis: an international consensus document.

Authors:  Francesco Emma; Galina Nesterova; Craig Langman; Antoine Labbé; Stephanie Cherqui; Paul Goodyer; Mirian C Janssen; Marcella Greco; Rezan Topaloglu; Ewa Elenberg; Ranjan Dohil; Doris Trauner; Corinne Antignac; Pierre Cochat; Frederick Kaskel; Aude Servais; Elke Wühl; Patrick Niaudet; William Van't Hoff; William Gahl; Elena Levtchenko
Journal:  Nephrol Dial Transplant       Date:  2014-09       Impact factor: 5.992

10.  Transplantation of wild-type mouse hematopoietic stem and progenitor cells ameliorates deficits in a mouse model of Friedreich's ataxia.

Authors:  Celine J Rocca; Spencer M Goodman; Jennifer N Dulin; Joseph H Haquang; Ilya Gertsman; Jordan Blondelle; Janell L M Smith; Charles J Heyser; Stephanie Cherqui
Journal:  Sci Transl Med       Date:  2017-10-25       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.